BeiGene announces Novartis collaboration on antibody
BeiGene announces Novartis collaboration on antibody By Liu Zhihua | chinadaily.com.cn | Updated: 2021-01-13 11:13 Share CLOSE Scientists discuss use of equipment at the central chemistry lab of BeiGene in Beijing in May 2017. [Photo provided to chinadaily.com.cn] China-based biotechnology company BeiGene Ltd held a media conference in Beijing on Tuesday to announce its collaboration and license agreement with Swiss pharmaceutical company Novartis Pharma AG for development and commercialization of the cancer treatment tislelizumab. Th...